Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection

M van der Valk, EH Gisolf, P Reiss, FWNM Wit, A Japour, GJ Weverling, SA Danner, - Prometheus study group, Marchina Ende, Jan Nouwen, R Deenenkamp, D van der Meyden

Research output: Contribution to journalArticleAcademicpeer-review

154 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)847-855
Number of pages9
Publication statusPublished - 2001

Research programs

  • EMC 05-03-38-04-00

Cite this